Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP1 | P22413 | 1/20 | 0.44 |
| ▸ | RNASEL | Q05823 | 9/20 | 0.42 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.41 |
| ▸ | P2RX4 | Q99571 | 2/20 | 0.41 |
| ▸ | P2RX2 | Q9UBL9 | 2/20 | 0.41 |
| ▸ | P2RX6 | O15547 | 1/20 | 0.41 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.41 |
| ▸ | P2RX5 | Q93086 | 1/20 | 0.41 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.41 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16288675 | 1.00 | ENPP1 (0.44) | ENPP1RNASELP2RX3P2RX4P2RX2 | |
| SCHEMBL16288670 | 1.00 | ENPP1 (0.44) | ENPP1RNASELP2RX3P2RX4P2RX2 | |
| SCHEMBL16574571 | 1.00 | ENPP1 (0.44) | ENPP1RNASELP2RX3P2RX4P2RX2 | |
| SCHEMBL16288673 | 1.00 | ENPP1 (0.44) | ENPP1RNASELP2RX3P2RX4P2RX2 | |
| SCHEMBL16288598 | 0.96 | ENPP1 (0.45) | ENPP1RNASELP2RX3P2RX4P2RX2 | |
| SCHEMBL15083235 | 0.96 | ENPP1 (0.45) | ENPP1RNASELP2RX3P2RX4P2RX2 | |
| SCHEMBL16288594 | 0.96 | ENPP1 (0.45) | ENPP1RNASELP2RX3P2RX4P2RX2 | |
| SCHEMBL16288592 | 0.96 | ENPP1 (0.45) | ENPP1RNASELP2RX3P2RX4P2RX2 | |
| SCHEMBL23140695 | 0.94 | ENPP1 (0.45) | ENPP1RNASELP2RX3P2RX4P2RX2 | |
| SCHEMBL16289006 | 0.94 | ENPP1 (0.45) | ENPP1RNASELP2RX3P2RX4P2RX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013100132-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | 中外製薬株式会社 (JP) | 2013-07-04 | — | — | WO | disclosed |